Daclatasvir plus Asunaprevir Treatment for Real-World HCV Genotype 1-Infected Patients in Japan

Lignende værker

• Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin
  af: Kanda, Tatsuo, et al.
  Udgivet: (2017)
• Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b, who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literature
  af: Haga, Yuki, et al.
  Udgivet: (2017)
• Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin
  af: Kanda, Tatsuo, et al.
  Udgivet: (2016)
• Effect of Hepatitis C Virus Genotype 1b Core and NS5A Mutations on Response to Peginterferon Plus Ribavirin Combination Therapy
  af: Nakamoto, Shingo, et al.
  Udgivet: (2015)
• Sofosbuvir treatment and hepatitis C virus infection
  af: Nakamura, Masato, et al.
  Udgivet: (2016)